This study aims to explore the value of MIC-1 as a biomarker in the onset of lung cancer, and furthermore, using MIC-1 as a critical factor, construct predictive panel for the preselection of potential risk subjects, which may facilitate the widespread implementation of LDCT screening and enhance its cost-effectiveness. The gene discussed is GDF15; the disease is lung carcinoma.